Literature DB >> 26053522

Runx1 and Runx3 Are Downstream Effectors of Nanog in Promoting Osteogenic Differentiation of the Mouse Mesenchymal Cell Line C3H10T1/2.

Tadahito Saito1,2, Shinsuke Ohba3, Fumiko Yano1, Ichiro Seto1, Yoshiyuki Yonehara2, Tsuyoshi Takato1, Toru Ogasawara1.   

Abstract

Previously, we reported that the transcription factor Nanog, which maintains the self-renewal of embryonic stem cells (ESCs), promotes the osteogenic differentiation of the mouse mesenchymal cell line C3H10T1/2 through a genome reprogramming process. In the present study, to clarify the mechanism underlying the multipotency of mesenchymal stem cells (MSCs) and to develop a novel approach to bone regenerative medicine, we attempted to identify the downstream effectors of Nanog in promoting osteogenic differentiation of mouse mesenchymal cells. We demonstrated that Runx1 and Runx3 are the downstream effectors of Nanog, especially in the early and intermediate osteogenic differentiation of the mouse mesenchymal cell line C3H10T1/2.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26053522      PMCID: PMC4487263          DOI: 10.1089/cell.2014.0059

Source DB:  PubMed          Journal:  Cell Reprogram        ISSN: 2152-4971            Impact factor:   1.987


  34 in total

1.  Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells.

Authors:  Ian Chambers; Douglas Colby; Morag Robertson; Jennifer Nichols; Sonia Lee; Susan Tweedie; Austin Smith
Journal:  Cell       Date:  2003-05-30       Impact factor: 41.582

2.  Runx2 and Runx3 are essential for chondrocyte maturation, and Runx2 regulates limb growth through induction of Indian hedgehog.

Authors:  Carolina A Yoshida; Hiromitsu Yamamoto; Takashi Fujita; Tatsuya Furuichi; Kosei Ito; Ken-ichi Inoue; Kei Yamana; Akira Zanma; Kenji Takada; Yoshiaki Ito; Toshihisa Komori
Journal:  Genes Dev       Date:  2004-04-15       Impact factor: 11.361

3.  Causal relationship between the loss of RUNX3 expression and gastric cancer.

Authors:  Qing Lin Li; Kosei Ito; Chohei Sakakura; Hiroshi Fukamachi; Ken ichi Inoue; Xin Zi Chi; Kwang Youl Lee; Shintaro Nomura; Chang Woo Lee; Sang Bae Han; Hwan Mook Kim; Wun Jae Kim; Hiromitsu Yamamoto; Namiko Yamashita; Takashi Yano; Toshio Ikeda; Shigeyoshi Itohara; Johji Inazawa; Tatsuo Abe; Akeo Hagiwara; Hisakazu Yamagishi; Asako Ooe; Atsushi Kaneda; Takashi Sugimura; Toshikazu Ushijima; Suk Chul Bae; Yoshiaki Ito
Journal:  Cell       Date:  2002-04-05       Impact factor: 41.582

4.  Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells.

Authors:  Janne L Simonsen; Cecilia Rosada; Nedime Serakinci; Jeannette Justesen; Karin Stenderup; Suresh I S Rattan; Thomas G Jensen; Moustapha Kassem
Journal:  Nat Biotechnol       Date:  2002-06       Impact factor: 54.908

5.  Runx3 is essential for the target-specific axon pathfinding of trkc-expressing dorsal root ganglion neurons.

Authors:  Ken-ichi Inoue; Shigeru Ozaki; Kosei Ito; Tsutomu Iseda; Saburo Kawaguchi; Masaharu Ogawa; Suk-Chul Bae; Namiko Yamashita; Shigeyoshi Itohara; Norio Kudo; Yoshiaki Ito
Journal:  Blood Cells Mol Dis       Date:  2003 Mar-Apr       Impact factor: 3.039

6.  Possible roles of Runx1 and Sox9 in incipient intramembranous ossification.

Authors:  Takashi Yamashiro; Xiu-Ping Wang; Zhe Li; Shinji Oya; Thomas Aberg; Tomohiro Fukunaga; Hiroshi Kamioka; Nancy A Speck; Teruko Takano-Yamamoto; Irma Thesleff
Journal:  J Bone Miner Res       Date:  2004-08-03       Impact factor: 6.741

7.  The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells.

Authors:  Kaoru Mitsui; Yoshimi Tokuzawa; Hiroaki Itoh; Kohichi Segawa; Mirei Murakami; Kazutoshi Takahashi; Masayoshi Maruyama; Mitsuyo Maeda; Shinya Yamanaka
Journal:  Cell       Date:  2003-05-30       Impact factor: 41.582

8.  The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons.

Authors:  Ditsa Levanon; David Bettoun; Catherine Harris-Cerruti; Eilon Woolf; Varda Negreanu; Raya Eilam; Yael Bernstein; Dalia Goldenberg; Cuiying Xiao; Manfred Fliegauf; Eitan Kremer; Florian Otto; Ori Brenner; Aharon Lev-Tov; Yoram Groner
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

9.  Runx1/AML1 hematopoietic transcription factor contributes to skeletal development in vivo.

Authors:  Jane B Lian; Eva Balint; Amjad Javed; Hicham Drissi; Regan Vitti; Edward J Quinlan; Lina Zhang; Andre J Van Wijnen; Janet L Stein; Nancy Speck; Gary S Stein
Journal:  J Cell Physiol       Date:  2003-08       Impact factor: 6.384

10.  AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis.

Authors:  T Okuda; J van Deursen; S W Hiebert; G Grosveld; J R Downing
Journal:  Cell       Date:  1996-01-26       Impact factor: 41.582

View more
  2 in total

1.  RUNX3 derived hsa_circ_0005752 accelerates the osteogenic differentiation of adipose-derived stem cells via the miR-496/MDM2-p53 pathway.

Authors:  Ming Wang; Yifan Huan; Xiyang Li; Jing Li; Guohua Lv
Journal:  Regen Ther       Date:  2021-10-21       Impact factor: 3.419

2.  Mechanisms of miR‑128‑3p in inhibiting osteoblast differentiation from bone marrow‑derived mesenchymal stromal cells.

Authors:  Wen Zhang; Yu Zhu; Junsheng Chen; Jiaxing Wang; Chen Yao; Chen Chen
Journal:  Mol Med Rep       Date:  2020-10-14       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.